Rhenium-188 and Copper-67 Radiopharmaceuticals for the Treatment of Bladder Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|4|1|61-68

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.4, Iss.1, 2004-01, pp. : 61-68

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mixed Tridentate π -Donor and Monodentate π -Acceptor Ligands as Chelating Systems for Rhenium-188 and Technetium-99m Nitrido Radiopharmaceuticals

By  

Current Radiopharmaceuticals, Vol. 6, Iss. 3, 2013-09 ,pp. : 137-145

Bentham Science Publishers

Access to resources Recommend Favorite

Gemcitabine in the treatment of bladder cancer

By Ryan C.W.   Vogelzang N.J.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 3, 2000-03 ,pp. : 547-553

Informa Healthcare

Access to resources Recommend Favorite

Production and Application of Copper Radiopharmaceuticals

By  

Current Radiopharmaceuticals, Vol. 2, Iss. 2, 2009-04 ,pp. : 92-101

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Copper Radiopharmaceuticals

By  

Current Radiopharmaceuticals, Vol. 4, Iss. 2, 2011-04 ,pp. : 109-121

Bentham Science Publishers

Access to resources Recommend Favorite

Therapy of Hepatocellular Carcinoma with Rhenium-188 Lipiodol

By  

Current Radiopharmaceuticals, Vol. 1, Iss. 2, 2008-05 ,pp. : 87-92

Bentham Science Publishers

Access to resources Recommend Favorite